Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
435
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
+184K
-
Total reported value, excl. options
-
$8.73B
-
Value change
-
+$29.5M
-
Put/Call ratio
-
0.41
-
Number of buys
-
194
-
Number of sells
-
-213
-
Price
-
$164.37
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2021
511 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q1 2021.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 435 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
.
Largest 10 shareholders include BlackRock Inc. (6.57M shares), VANGUARD GROUP INC (5.04M shares), FMR LLC (3.54M shares), RENAISSANCE TECHNOLOGIES LLC (2.66M shares), STATE STREET CORP (2.2M shares), LSV ASSET MANAGEMENT (2.07M shares), JPMORGAN CHASE & CO (1.9M shares), WELLINGTON MANAGEMENT GROUP LLP (1.56M shares), CITADEL ADVISORS LLC (1.35M shares), and AQR CAPITAL MANAGEMENT LLC (1.07M shares).
This table shows the top 435 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.